Bone health after diagnosis of breast cancer

Ruzycki offers five things to know about bone health after diagnosis of breast cancer. These include, treatment of breast cancer may increase fracture risk, patients with breast cancer should be assessed for fracture risk using a validated tool and bone is the most common site of metastases for pati...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2018-12, Vol.190 (49), p.E1452-E1452
Main Authors: Ruzycki, Shannon M., MD, Nixon, Nancy A., MD
Format: Article
Language:English
Subjects:
Analysis
Aromatase inhibitors
Aromatase Inhibitors - adverse effects
Bone density
Bone Density Conservation Agents - therapeutic use
Bone Neoplasms - drug therapy
Bone Neoplasms - prevention & control
Bone Neoplasms - secondary
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Cancer diagnosis
Cancer metastasis
Cancer patients
Cancer therapies
Cancer treatment
Diagnosis
Diphosphonates - therapeutic use
Female
Fractures
Fractures (Injuries)
Health risk assessment
Humans
Internal Medicine
Medical diagnosis
Medical research
Menopause
Metastasis
Neoplasm Staging
Osteoporosis
Osteoporosis - chemically induced
Osteoporosis - drug therapy
Osteoporotic Fractures - prevention & control
Postmenopause
Practice
Premenopause
Risk Assessment
Risk factors
Survival Rate
Women's health
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ruzycki offers five things to know about bone health after diagnosis of breast cancer. These include, treatment of breast cancer may increase fracture risk, patients with breast cancer should be assessed for fracture risk using a validated tool and bone is the most common site of metastases for patients with breast cancer.
ISSN:0820-3946
1488-2329
DOI:10.1503/cmaj.180802